SEOUL, South Korea -- MAYPHARM, a global aesthetic and cosmeceutical company, has announced the launch of HYALMASS AQUATOX. The new multi-active formulation designed to respond to the rapidly evolving demands of the global aesthetic market.
HYALMASS AQUATOX brings together five high-interest active ingredients: PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid. Botulinum Peptide is designed to support a smoother, more refined skin appearance. GHK-Cu is a copper peptide widely studied for skin conditioning and regeneration-related applications. Succinic Acid is recognized for its role in skin revitalization and antioxidant-related activity.
PDRN is associated with skin regeneration and recovery, and Exosomes are increasingly recognized for their role in advanced skin rejuvenation approaches. With the combination of these ingredients in the formulation,
HYALMASS AQUATOX seeks ti address the growing global demand for multifunctional, ingredient-driven aesthetic solutions.
A New Chapter for the HYALMASS Portfolio
The launch follows the growing international interest in HYALMASS AQUA EXOSOME, and strengthens MAYPHARM's expanding presence in the global aesthetic market. The company is emphasizing the importance of product authenticity and authorized distribution when purchasing HYALMASS products at a time when the demand for advanced skin rejuvenation products and there are increasing numbers of products on the market that are adopting similar visual identities, positioning and ingredient concepts. The company is urging distributors, aesthetic professionals and customers to verify the original manufacturer, authorized supply channel, packaging, and official product information before purchasing or using HYALMASS products.
